OM DENNE EPISODE
4basebio PLC (AIM:4BB, FRA:8L7, ETR:88Q) CEO Amy Walker joined Proactive's Stephen Gunnion to discuss the company's synthetic DNA platform, growing commercial momentum and key milestones for investors.
Walker explained how 4basebio's enzyme-based technology provides a cleaner, faster and more cost-effective alternative to conventional plasmid DNA manufacturing, supporting applications in cell and gene therapy, vaccines and gene editing. She also highlighted the launch of the company's single-stranded DNA product, which offers lower toxicity and the ability to produce longer DNA molecules for advanced gene editing.
The interview also covers a recent Phase 2 clinical supply agreement, the appointment of mRNA expert Jeff Coller to the Strategic Advisory Board, expansion of the company's Cambridge manufacturing facility and the commercial milestones investors should watch for over the coming months.
For more interviews and market insights, visit Proactive's YouTube channel. Don't forget to like this video, subscribe to the channel and enable notifications so you never miss future content.
#4basebio #SyntheticDNA #DNAManufacturing #GeneEditing #CRISPR #CellTherapy #GeneTherapy #Biotech #Biotechnology #LifeSciences #mRNA #Vaccines #PersonalizedMedicine #CancerVaccines #HealthcareInnovation #ClinicalTrials #CambridgeBiotech #Investing #SmallCapStocks #ProactiveInvestors
Walker explained how 4basebio's enzyme-based technology provides a cleaner, faster and more cost-effective alternative to conventional plasmid DNA manufacturing, supporting applications in cell and gene therapy, vaccines and gene editing. She also highlighted the launch of the company's single-stranded DNA product, which offers lower toxicity and the ability to produce longer DNA molecules for advanced gene editing.
The interview also covers a recent Phase 2 clinical supply agreement, the appointment of mRNA expert Jeff Coller to the Strategic Advisory Board, expansion of the company's Cambridge manufacturing facility and the commercial milestones investors should watch for over the coming months.
For more interviews and market insights, visit Proactive's YouTube channel. Don't forget to like this video, subscribe to the channel and enable notifications so you never miss future content.
#4basebio #SyntheticDNA #DNAManufacturing #GeneEditing #CRISPR #CellTherapy #GeneTherapy #Biotech #Biotechnology #LifeSciences #mRNA #Vaccines #PersonalizedMedicine #CancerVaccines #HealthcareInnovation #ClinicalTrials #CambridgeBiotech #Investing #SmallCapStocks #ProactiveInvestors
Engelsk
USA
UDSKRIFT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SØK BLANT TIDLIGERE EPISODER
Søk etter gamle episoder av Proactive - Interviews for investors.
ANDRE EPISODE I DENNE PODKAST
Rome Resources Plc (AIM:RMR) CEO Paul Barrett spoke with Proactive's Stephen Gunnion about a 2.6km tin-bearing trend at the company’s New Brunswick exploration project in Canada, promising tin and tungsten results and plans to advance towards drilling in 2027.
Barrett described the discovery as ev…
S&U PLC (LSE:SUS) chairman Anthony Coombs spoke with Proactive's Stephen Gunnion about the group’s new £600 million funding facilities, which replace £330 million of existing arrangements at improved rates and support its next phase of growth.
Coombs described the deal as transformational, giv…
FireFly Metals Ltd managing director Steve Parsons talked with Proactive about the company’s latest copper-gold discovery at the Mount Joy prospect within the Green Bay Project in Newfoundland, Canada, and the wider regional exploration program underway around the proposed Ming Mine restart.
Parso…
Resolution Minerals Ltd US operations chief executive Craig Lindsay talked with Proactive about the latest drilling results from the company’s 100%-owned Horse Heaven Project in Idaho, where Golden Gate North has developed into a broad gold-mineralised system extending for at least 500 metres.
Lin…
VivoPower International PLC Chief Investment Officer Alex Cuppage joined Steve Darling from Proactive to discuss the company's agreement with UAE-based Open Innovation AI to jointly explore and develop secure sovereign AI data centres across the Nordic countries, mainland Europe, the Gulf Cooperati…
Ansvarsfraskrivelse: Podkasten og kunstværket, det finnes indlejret på denne siden, er fra Proactive, som tilhører dens eier og ikke er tilknyttet eller godkjent av Listen Notes, Inc.
REDIG
Takk fordi du hjelper med å holde podkast-databasen oppdatert.
